This inventor holds 8 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Paladin Labs (Barbados) Inc., Paladin Labs Europe Limited, Paladin Labs Inc.. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Montreal, CA (2013)
- Beaconsfield, CA (2014 - 2015)
Company Filing History:
8 out of 12 
8 out of 11 
8 out of 17 
Years Active: 2013-2015
Title: The Innovative Journey of Inventor Ali El-Jammal
Introduction
Ali El-Jammal is a distinguished inventor based in Beaconsfield, CA, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of eight patents to his name, his innovations are aimed at enhancing the efficacy and safety of medications.
Latest Patents
One of Ali El-Jammal's notable inventions is a misuse preventative, controlled release formulation, which is designed to mitigate the risk of misuse of medications, particularly opioid analgesics. This innovative composition features a multilayered oral dosage form with a first layer containing controlled release microparticles that house a pharmaceutically active agent. The second layer incorporates a superabsorbent material, which when subjected to crushing or exposure to an aqueous medium, swells to create a hard gel that encapsulates the microparticles. This mechanism ensures that the release of the pharmaceutically active agent is retarded, allowing for a safer management of medications without compromising their therapeutic effects.
Career Highlights
Throughout his career, Ali El-Jammal has worked with esteemed companies such as Paladin Labs Inc. and Paladin Labs (Barbados) Inc., where he has made significant contributions to research and development initiatives. His expertise in formulating controlled release systems has positioned him as a leader in the field of pharmaceutical innovation.
Collaborations
Ali has collaborated with talented professionals like Miloud Rahmouni and Sonia Gervais. These partnerships have fostered a creative environment, leading to advancements in drug delivery systems that prioritize patient safety and therapeutic effectiveness.
Conclusion
Ali El-Jammal’s dedication to innovation in pharmaceuticals not only highlights his inventiveness but also his commitment to patient welfare. His latest patents reflect a proactive approach to mitigating the risks associated with medication use, ensuring that his inventions contribute positively to public health. As he continues to develop innovative solutions, the impact of his work will undoubtedly resonate within the pharmaceutical industry for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile